- Home
- CDXS vs NAUT Comparison
CDXS vs NAUT Comparison
Compare CDXS & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- NAUT
- Stock Information
- Founded
- CDXS 2002
- NAUT 2016
- Country
- CDXS United States
- NAUT United States
- Employees
- CDXS N/A
- NAUT N/A
- Industry
- CDXS Major Chemicals
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- CDXS Industrials
- NAUT Industrials
- Exchange
- CDXS Nasdaq
- NAUT Nasdaq
- Market Cap
- CDXS 332.0M
- NAUT 284.7M
- IPO Year
- CDXS 2010
- NAUT N/A
- Fundamental
- Price
- CDXS $5.28
- NAUT $1.76
- Analyst Decision
- CDXS Buy
- NAUT Hold
- Analyst Count
- CDXS 2
- NAUT 3
- Target Price
- CDXS $11.00
- NAUT $3.58
- AVG Volume (30 Days)
- CDXS 875.4K
- NAUT 172.2K
- Earning Date
- CDXS 10-31-2024
- NAUT 10-29-2024
- Dividend Yield
- CDXS N/A
- NAUT N/A
- EPS Growth
- CDXS N/A
- NAUT N/A
- EPS
- CDXS N/A
- NAUT N/A
- Revenue
- CDXS $64,446,000.00
- NAUT N/A
- Revenue This Year
- CDXS N/A
- NAUT N/A
- Revenue Next Year
- CDXS $2.02
- NAUT N/A
- P/E Ratio
- CDXS N/A
- NAUT N/A
- Revenue Growth
- CDXS N/A
- NAUT N/A
- 52 Week Low
- CDXS $2.53
- NAUT $1.74
- 52 Week High
- CDXS $6.08
- NAUT $3.46
- Technical
- Relative Strength Index (RSI)
- CDXS 59.97
- NAUT 30.63
- Support Level
- CDXS $5.42
- NAUT $1.88
- Resistance Level
- CDXS $6.01
- NAUT $2.10
- Average True Range (ATR)
- CDXS 0.39
- NAUT 0.16
- MACD
- CDXS -0.05
- NAUT -0.02
- Stochastic Oscillator
- CDXS 46.67
- NAUT 3.77
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.